Latest Breaking News On - Thenew england journal - Page 12 : comparemela.com

Perioperative Nivolumab Plus Chemo Improves pCR, Survival in Stage III NSCLC

Neoadjuvant treatment with nivolumab plus platinum-based chemotherapy followed by adjuvant nivolumab increased pathological complete response rates and prolonged survival compared with neoadjuvant chemotherapy alone in patients with resectable stage IIIA/B non–small cell lung cancer.

Mariano provencioThenew england journalMedical oncology departmentPuerta de hierro university hospitalAutonomous universityImmunotherapy in lung cancerLung cancerThe new england journal of medicinePhase 2 nadim ii trial

Daily Statin Cuts Cardiovascular Risk in HIV

Final data from the REPRIEVE trial show pitavastatin therapy is associated with a significantly lower risk of cardiovascular events than placebo as evidence grows for statins in primary prevention.

United statesCity ofUnited kingdomSouth africaMarkella zanniSteven grinspoonHarvard medical schoolSociety conferenceMortimer market centreMassachusetts general hospitalThenew england journalMedscape medicalAtherosclerotic cardiovascular diseaseSouth asianLaura watersMarket centre

Mirikizumab induces, maintains remission among nearly 50% of patients with UC at 40 weeks

Mirikizumab induces, maintains remission among nearly 50% of patients with UC at 40 weeks
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Noord hollandBykate burbaBristol meyers squibbGeert dhaensKristen dowdEli lillyAmsterdam university medical centerBoehringer ingelheimGilead sciencesThenew england journal

OpenEvidence AI Becomes the First AI in History to Score Above 90% on the United States Medical Licensing Examination (USMLE)

/PRNewswire/ OpenEvidence, a generative Artificial Intelligence (AI) company working on aligning Large Language Models (LLMs) to the medical domain,.

United statesUnited kingdomEric lehmanDaniel nadlerPrnewswire openevidenceZachary zieglerJonas wulffNevan hernandezMicah smithHarvard medical schoolConference on healthFounding teamTheassociation for healthArtificial intelligenceLarge language modelsUnited states medical licensing examination

Pirtobrutinib produces high response rates in heavily pretreated CLL, SLL

Pirtobrutinib produces high response rates in heavily pretreated CLL, SLL
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Eli lilly coThenew england journalAnthonyr matoChronic lymphocytic leukemia programMemorial sloan kettering cancer centerEli lilly